Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00856453 · ClinicalTrials.gov registry record · NA

Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer

A NA study, sponsored by Wake Forest University Health Sciences.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT00856453 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 2 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00856453, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

RATIONALE: Yoga may decrease fatigue, distress, and depression, and improve sleep quality in patients undergoing chemotherapy for ovarian cancer. It is not yet known whether practicing yoga in group classes is more effective than practicing yoga at home. PURPOSE: This randomized clinical trial is studying how well yoga works in relieving fatigue in patients undergoing chemotherapy for ovarian cancer.

Interventions

  • BEHAVIORAL yoga classes
  • BEHAVIORAL Home yoga practice

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2009-05
Est. Completion 2009-10
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT00856453

The ClinicalTrials.gov registry entry for NCT00856453 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which yoga classes is the first listed.

NCT00856453 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00856453 about?

NCT00856453 is a clinical study titled "Yoga in Relieving Fatigue in Patients Undergoing Chemotherapy for Ovarian Cancer". RATIONALE: Yoga may decrease fatigue, distress, and depression, and improve sleep quality in patients undergoing chemotherapy for ovarian cancer. It is not yet known whether practicing yoga in group classes is more effective than practicing yoga at home. PURPOSE: This randomized clinical trial is s...

What is the current status of trial NCT00856453?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-05. Estimated completion is 2009-10.

What interventions are being tested in trial NCT00856453?

The interventions under investigation include: yoga classes (BEHAVIORAL), Home yoga practice (BEHAVIORAL).

Who is sponsoring clinical trial NCT00856453?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.